Catalyst Reactivate
Catalyst Reactivate provides the world's first pharmaceutical-grade H₂O₂ catalyst reactivation service for cleanroom isolators, validated under ISO 15202 with accredited third-party testing on every batch. The low-temperature, electrically controlled process restores catalyst surface activity and returns units in days rather than weeks, at a cost below purchasing new catalysts. Each order includes QMS-compatible documentation and batch-level CO₂e savings reports for ESG disclosures.
- Chemical Technology
- Clean Technology
- Manufacturing / Industry 4.0
Funding
Founders
Founder details are not available yet.
Product
Problem
Pharmaceutical facilities running H₂O₂ decontamination in isolators must replace spent catalysts, a process that involves long procurement lead times, high costs, and significant environmental burden from manufacturing new Pt/Al₂O₃ substrates. This linear "use and discard" model creates unnecessary downtime and waste for GMP-regulated environments.
Solution
Catalyst Reactivate provides the world's first pharmaceutical-grade H₂O₂ catalyst reactivation service, validated under ISO 15202 with accredited third-party testing on every batch. The service uses a low-temperature, electrically controlled oxidative treatment with temperature-controlled enrichment to restore catalyst surface activity, returning units in days rather than weeks. Each order includes QMS-compatible documentation, a before-and-after performance report, and logistics back to the facility, ensuring validated safe re-entry into cleanroom operations. This circular regeneration approach extends catalyst lifetime, reduces CO₂e emissions, and provides batch-level sustainability data reportable in ESG disclosures.
Target Audience
Primary customers are pharmaceutical manufacturers and GMP-regulated facilities operating H₂O₂ decontamination systems in cleanroom isolators, including quality, maintenance, and sustainability teams seeking validated, cost-effective catalyst lifecycle management.
Features
- ISO 15202 (ICP-QMS) accredited third-party testing on every batch, validating safe cleanroom re-entry with zero contamination risk
- Low-temperature reactivation process with controlled oxidative treatment and temperature-controlled enrichment to restore surface activity
- QMS-compatible documentation delivered with every order, including before-and-after performance reports
- Typical lead time measured in days, with pooling concepts available for facilities with multiple units
- Batch-level CO₂e savings reports aligned with pharmaceutical sustainability commitments and ESG disclosure requirements
- Free 30-minute technical screening call to confirm catalyst type, material, and application before any commitment
- Verified customer outcome: a global pharmaceutical manufacturer reinstalled a reactivated catalyst on a high-capacity vial filling line, resolving an observed capacity challenge